Connect with us

Health

COVID-19: Seven have died in UK after receiving AstraZeneca vaccine, says regulator

Published

on

The UK medical regulator said Saturday that out of 30 people who suffered rare blood clots after receiving the Oxford-AstraZeneca vaccine, seven have died.

The British acknowledgement of deaths comes as several European countries have paused the use of the AstraZeneca jab over a potential link to blood clots.

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) said in a statement that “Out of the 30 reports up to and including 24 March, sadly 7 have died.”

The reports of thrombosis, submitted by medics or members of the public via a government website, came after 18.1 million doses of the vaccine had been administered in the country.

Most of the cases (22) were a rare clotting condition called cerebral venous sinus thrombosis. Eight cases saw people suffer other types of thrombosis combined with low levels of blood platelets, which help blood clot.

There were no reports of blood clots from the Pfizer-BioNTech vaccine, the UK regulator said, adding that “our thorough review into these reports is ongoing”.

But MHRA chief executive Dr June Raine stressed that the benefits far outweighed any risks. “The public should continue to get their vaccine when invited to do so,” she said.

Europe update expected

Both the MHRA and European Medicines Agency (EMA) say no causal link has yet been established between the blood clotting case and the AstraZeneca vaccine.

ALSO READ  One Killed In Abuja Flood {Photos}

But growing concerns have prompted a number of countries to pause rollout of the vaccine or limit it to older people due to the relatively young age of those who suffered blood clots.

Netherlands on Friday halted vaccinations with the AstraZeneca jab for people under the age of 60 after five new cases among younger women, one of whom died.

Germany has suspended the use of the vaccine for those under 60 after 31 cases of blood clots, most of them among younger and middle-aged women.

A number of other countries including France have imposed a similar age restrictions, while Denmark and Norway have suspended all use of the vaccine.

The European Medicines Agency (EMA), which like the World Health Organization previously declared the AstraZeneca vaccine safe, is expected to announce updated advice on the issue on April 7.

It said Wednesday that there had been 62 cases worldwide of cerebral venous sinus thrombosis, 44 of them in the European Economic Area, which includes the European Union, Iceland, Liechtenstein and Norway.

This figure did not include all Germany’s cases, however.

More than 9.2 million AstraZeneca jabs have been administered in the region.

The EMA said it believes the vaccine is safe and that experts have found no specific risk factors such as age, gender or medical history.

ALSO READ  COVID-19: Poor people in Africa to increase by 49.2m in 2021, Nigeria to record largest increase - AfDB reveals

‘Weight of evidence’

Paul Hunter, a medical microbiologist at Britain’s University of East Anglia, told AFP that he had initially thought the link between vaccination and blood clots was likely to be a “random association”.

As evidence mounts of clusters in separate countries, “the weight of evidence is now looking towards Oxford-AstraZeneca actually being the cause of these adverse events”, he said.

Nevertheless, the risk for the unvaccinated of dying from Covid is “substantially greater,” he said.

A spokeswoman for AstraZeneca told AFP that patient safety is its “highest priority”.

UK, EU and World Health Organization regulatory bodies have concluded that the benefits “significantly outweigh the risks across all adult age groups”, she said.

AstraZeneca said last month following US efficiency trials that its vaccine is 76 percent effective at preventing the disease. It also said data for the EU and the UK showed no increased risk of blood clots.

The UK has administered more than 31 million first vaccine doses, using both the Oxford-AstraZeneca and the Pfizer-BioNTech jabs. People cannot choose which one they get.

The UK in June 2020 ordered 100 million doses of the Oxford-AstraZeneca vaccine and supported its development. It also ordered 30 million doses of the Pfizer-BioNTech vaccine the same year.

ALSO READ  Oyo lawmaker rekindles hope for constituents

 

AFP

Comments

Health

Ondo Resident Doctors Begin 14-Day Warning Strike

Published

on

By

Resident doctors at the University of Medical Sciences Teaching Hospital (UNIMEDTH) in Ondo State have initiated a 14-day warning strike, as confirmed by the National Association of Resident Doctors (NARD).

The strike action, led by the association’s President, John Matthew, highlights various grievances, notably the non-payment of seven months’ salaries to new members.

Matthew added that the strike also addresses the non-payment of palliative to House Officers since February, the failure to disburse the February Hazard Allowance despite prior assurances from the state government, and the ongoing shortage of staff due to resignations.

Matthew lamented the drastic decrease in resident doctors, citing a decrease from 150 doctors to a mere 26 in recent months.

In response to the situation, he urged management to prioritise the full payment of arrears owed to members, immediate payment of the February 2024 palliative to house officers, and prompt disbursement of the February hazard allowance.

The association further called for urgent measures to address the critical shortage of clinical manpower within the institution.

Continue Reading

Health

FG Okays N25bn Disbursement to Enhance Healthcare Delivery

Published

on

By

File photo of the Coordinating Minister of Health and Social Welfare, Ali Pate,

The Federal Government has greenlit the allocation of N25 billion to bolster the efforts of the National Primary Healthcare Development Agency (NPHCDA) and the National Health Insurance Authority (NHIA) in advancing healthcare accessibility and quality across Nigeria.

The Coordinating Minister of Health and Social Welfare, Ali Pate, made this known, stressing the steadfast commitment of the current administration towards revamping the healthcare system to achieve Universal Healthcare Coverage (UHC) for all Nigerians.

In a statement by Deworitshe Patricia, a spokesperson for the ministry, Pate emphasised that the government’s strategy for health sector transformation involves the implementation of a Sector Wide Approach (SWAp) and the Health Sector Renewal Investment Programme (NHSRIP).

Addressing the imperative for reforms in Nigeria’s primary healthcare delivery, Pate highlighted the significance of revising the Basic Healthcare Provision Fund (BHCPF) and its associated programmes.

Pate outlined the objectives of the revised guidelines, which include expanding healthcare services for underserved populations, particularly women and children, reducing maternal mortality rates, alleviating out-of-pocket healthcare expenses, and standardizing healthcare quality across primary healthcare facilities nationwide.

“The Ministry, in collaboration with development partners, is dedicated to ensuring equitable access to healthcare services for all Nigerians, with a special focus on vulnerable groups,” stated Pate. “Through initiatives like NHSRIP, we aspire to minimize the need for long-distance travel for medical care, thereby improving the overall health outcomes and well-being of our citizens.”

ALSO READ  Queen Elizabeth II turns 96

 

Continue Reading

Health

Photos: Saudi Medical Team Make History, Separate Nigerian Conjoined Twins

Published

on

By

In a monumental achievement for medical science, a team of Saudi professionals at the King Abdullah Specialist Children’s Hospital has completed the separation surgery of Nigerian conjoined twins, Hassana and Husaina.

The directive for this historic achievement came from the Custodian of the Two Holy Mosques King Salman bin Abdulaziz Al-Saud and His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al-Saud, Crown Prince and Prime Minister, demonstrating the Kingdom’s commitment to advancing healthcare.

The complex procedure, initiated on Thursday morning, was the result of meticulous planning and execution by a dedicated team of 38 medical experts. This group included consultants, specialists, technicians, and nursing staff, all working in harmony to address shared areas in the lower abdomen, pelvis, lower spine, and lower spinal nerves of the twins.

The surgery, unfolding in nine carefully planned stages, lasted approximately 14 hours. Dr. Abdullah Al Rabeeah, Advisor at the Royal Court, Supervisor General of the King Salman Humanitarian Aid and Relief Center (KSrelief), and head of the medical team, expressed confidence in the success of the procedure, citing a noteworthy 70% success rate.

“This is a momentous occasion that showcases the Kingdom’s commitment to advancing medical science and providing compassionate healthcare globally,” he said.

ALSO READ  Ajimobi was a pride of Ibadan land, great achiever - Alli

The successful separation of Hassana and Husaina commemorates the 60th operation conducted by the Saudi programme for separating conjoined twins. Over the past 34 years, this programme has offered care to 135 conjoined twins from 25 countries.

Dr. Al Rabeeah expressed heartfelt gratitude and appreciation to the Saudi leadership for their steadfast support of the programme.

He said, “The successful separation of Hassana and Husaina exemplifies the Kingdom’s dedication to humanitarian causes and its role as a leader in global healthcare.”

The Press Attaché at the Saudi embassy in Abuja, Mohammed Alsahabi, remarked on the accomplishment, stating, “This remarkable feat underscores the strong collaboration between Saudi Arabia and Nigeria in healthcare. We take pride in contributing to the improvement of these twins’ lives and their families.”

The separation of Hassana and Husaina represents not just a medical triumph but also serves as a symbol of hope for numerous individuals confronting similar challenges globally.

Continue Reading
Advertisement

Tweets by ‎@megaiconmagg

Subscribe to our Newsletter

* indicates required

MegaIcon Magazine Facebook Page

Advertisement

MEGAICON TV

Trending